Probasin (PB)

Probasin is a low-molecular-weight, androgen-regulated secretory protein that belongs to the lipocalin superfamily, originally identified in the rat prostate (UniProt: P15399) [1][2]. It is characterized by its high level of tissue-specific expression within the epithelial cells of the prostate gland, making it a pivotal marker for studying androgen receptor signaling and prostatic development [2][3]. While Probasin itself is not a target for pharmacological agents in humans, it is of immense value in preclinical oncology research. The Probasin promoter, particularly the modified ARR2PB version, is widely used to create transgenic animal models like the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) model, which mimics the progression of human prostate cancer [3][4]. In the context of drug development, it serves as a tool for prostate-targeted gene delivery systems rather than a therapeutic target itself [5]. Consequently, its primary relevance to biotech analysts lies in its role as a gold-standard regulatory element for achieving organ-specific transgene expression in prostate research [4].

Other names

Rat probasinAndrogen-regulated prostate proteinPB proteinLipocalin-like prostate protein

Probasin is not a direct drug target for therapeutic inhibition or activation. Instead, its promoter (specifically the ARR2PB variant) is utilized as a regulatory element in gene therapy and transgenic modeling to drive the expression of therapeutic genes or oncogenes specifically within prostatic epithelial cells (e.g., the TRAMP model).